Scientists reverse congenital blindness in mouse model

A study funded by the National Eye Institute (NEI) has shown that congenital blindness in mice could be reversed by regenerating rod photoreceptors in the retina.

Photoreceptors in eye of mouse with congenital blindnessImage Credit: Bo Chen, Ph.D

The findings have important implications for research into regenerative therapies for diseases such as age-related macular degeneration and retinitis pigmentosa.

As reported in the journal Nature, researchers turned supportive cells called Müller glia into functional rod photoreceptors that could integrate with other types of neurons in the retina and brain.

Rods allow us to see in low light, but they may also help preserve cone photoreceptors, which are important for color vision and high visual acuity. Cones tend to die in later-stage eye diseases. If rods can be regenerated from inside the eye, this might be a strategy for treating diseases of the eye that affect photoreceptors."  

Thomas Greenwell, NEI Program Director for Retinal Neuroscience

The Müller glia have long been studied for their regenerative potential because they have previously been shown to undergo division in response to injury and change into photoreceptors and other neurons in the retina.

However, this has only been demonstrated in non-mammalian species such as zebra fish and scientists have found that to prompt mammalian Müller glia to behave similarly to how they do in fish, they need to injure the tissue first.

From a practical standpoint, if you're trying to regenerate the retina to restore a person's vision, it is counterproductive to injure it first to activate the Müller glia. We wanted to see if we could program Müller glia to become rod photoreceptors in a living mouse without having to injure its retina.”

Professor Bo Chen, Lead Investigator

To achieve this, Professor Bo Chen and colleagues first induced division of Müller glia in healthy mice by injecting a gene into the eye that activates a protein called beta-catenin.

Once the cells had divided, factors that prompt the cells to turn into rod photoreceptors were injected into the eyes and the new rods were tracked using microscopy.

Chen and team report that the regenerated rod photoreceptors appeared to have the same structure as naturally occurring photoreceptors.

They had also formed synaptic structures that enabled them to communicate with other retinal neurons.

To test whether the newly formed rods were functional, the researchers applied the approach to blind mice that had been born without functional rods.

They found that the rods derived from Müller glia developed just as well as they had in the healthy mice and were communicating with other types of neurons in the retina across synapses.

Further tests showed that the Müller glia-derived rods were integrated into the visual pathway circuitry connecting the retina and the brain’s primary visual cortex.

Next, the team plans to conduct studies that will show whether the mice have regained the ability to complete visual tasks and to test the effectiveness of the approach in human retinal tissue.


Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 19). Scientists reverse congenital blindness in mouse model. News-Medical. Retrieved on June 22, 2021 from

  • MLA

    Robertson, Sally. "Scientists reverse congenital blindness in mouse model". News-Medical. 22 June 2021. <>.

  • Chicago

    Robertson, Sally. "Scientists reverse congenital blindness in mouse model". News-Medical. (accessed June 22, 2021).

  • Harvard

    Robertson, Sally. 2019. Scientists reverse congenital blindness in mouse model. News-Medical, viewed 22 June 2021,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.